ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: SA-PO170

Angiotensin II Type 2 Receptor (AT2R) Modulates CD4+ T Cells into Regulatory T Cells (Tregs) in Kidney Ischemia-Reperfusion Injury in Rats: Role of PP2A

Session Information

  • AKI: Mechanisms - III
    November 04, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms


  • Faisal, Tahmid, University of Houston System, Houston, Texas, United States
  • Ali, Riyasat, University of Houston System, Houston, Texas, United States
  • Hussain, Tahir, University of Houston System, Houston, Texas, United States

Kidney ischemia reperfusion injury (IR) is the common pathophysiology of acute kidney injury (AKI) associated with immune cell infiltration including T cells. Male kidney is more susceptible to AKI than females. Recently, we have shown that IR causes infiltration of CD45+T cells in male rats and AT2R activation reduced renal CD45+ T cells infiltration and modulated CD4+T cells into anti-inflammatory Tregs ameliorating AKI. Infiltration of these cells in females and the mechanism of AT2R-mediated modulation of CD4T cells into Tregs are unknown.


Bilateral IR was performed on female SD rats for 30 mins. The rats were divided into 3 groups: sham,IR, and IR+C21 (AT2R agonist, i.p. 0.3 mg/kg b.wt). After 3 days kidney cells were isolated and analyzed with flow cytometry for investigating CD45+, CD3+, CD4+, and FoxP3+ Treg cells. Also B6 mouse splenic CD4+T cells were isolated using magnetically labelled anti-CD4, which were activated with anti-CD3/anti-CD28/ IL2/ TGFβ and treated with C21 alone or in the presence of AT2R antagonist PD123319, NO synthase inhibitor LNAME, PP2A inhibitor okadaic acid.


The female rats showed CD45+, CD3+ and CD4+ T cells infiltration 3days after IR. However, the renal accumulation of CD45 and Tregs is lower in female (<1% of total kidney cells) compared to 3 days IR data in male (7%) rats- suggesting a sex difference. C21 administration reduced the CD45+ T cells infiltration, and increased CD4+FoxP3+ regulatory T cells population and reduced kidney injury as evident by reduced plasma creatinine. However, BUN and proteinuria analysis did not suggest any significant changes with AT2R activation at 3 day post-IR. The ex-vivo splenic CD4+T cells revealed that C21 treatment modulated the CD4+T cells into CD4+Treg cells as determined by 2- fold increase in transcription factor FoxP3 expression. AT2R antagonist PD123319 reduced 2- fold, suggesting the involvement of AT2R. The PP2A inhibitor okadaic acid remarkably attenuated C21-induced FoxP3 increase indicating while the NO synthase inhibitor L-NAME caused only a moderate reduction in C21-induced FoxP3 expression.


IR causes a lower immune cell infiltration in females than males and the AT2R-mediated protection and Treg modulation occurs via PP2A pathway.


  • Other NIH Support